Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation THKKF


Primary Symbol: V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Apr 19, 2022 12:25pm
198 Views
Post# 34613530

THNK Go Private Discussions?

THNK Go Private Discussions?I've now heard from two industry sources that believe THNK is having go private and/or sale discussions with a strategic / Private Equity frim. This, they say, explains why an earnings announcement hasn't happened yet despite only 10 days remaining until end of the month, company switched to analyst expectations from their own guidance during recent conferences/presentations, and CFO departure (due to redundancy post transaction).

More broadly speaking I would say that M&A chatter in the healthTech space has definetely picked up so it may be possible that THNK has been approached. Lots of capital sitting on the sidelines looking for acquisitions. Would they do a deal? Tough to say but I'm sure managment is feeling frustrated at the significant loss in value of their shares/options since the IPO.
<< Previous
Bullboard Posts
Next >>